These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3309806)

  • 21. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition kinetics of dibekacin in patients with renal failure and in patients undergoing hemodialysis.
    Arancibia A; Baillarie D; Bravo M; Chávez J
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):623-7. PubMed ID: 8688988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial uptake of habekacin, a novel aminoglycoside antibiotic.
    Matsunaga K; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1984 May; 37(5):596-601. PubMed ID: 6376453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
    Rolin O; Bouanchaud DH
    Drugs Exp Clin Res; 1986; 12(11):885-7. PubMed ID: 3816504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis.
    Riccobene T; Jakate A; Rank D
    J Clin Pharmacol; 2014 Jul; 54(7):742-52. PubMed ID: 24431097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis.
    Fillastre JP; Taburet AM; Fialaire A; Etienne I; Bidault R; Singlas E
    Drugs Exp Clin Res; 1993; 19(1):25-32. PubMed ID: 8223137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of infusion time on the pharmacokinetics of dibekacin in rabbits.
    Navarro AS; Lanao JM; Dominguez-Gil A
    J Antibiot (Tokyo); 1984 Mar; 37(3):285-92. PubMed ID: 6725142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute toxicity and pharmacokinetics of dibekacin mice.
    Komiya I; Murata S; Umemura K; Tomono N; Kikai S; Fujita M
    J Pharmacobiodyn; 1981 May; 4(5):356-61. PubMed ID: 7288553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of habekacin, a novel aminoglycoside antibiotic, on experimental corneal ulceration due to Pseudomonas aeruginosa.
    Tanaka Y
    J Antibiot (Tokyo); 1981 Jul; 34(7):892-7. PubMed ID: 7287591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of some aminoglycoside antibiotics in the horse.
    Baggot JD; Love DN; Rose RJ; Raus J
    J Vet Pharmacol Ther; 1981 Dec; 4(4):277-84. PubMed ID: 7349342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of dibekacin after intramuscular administration in man.
    Umemura K; Komiya I; Nakadori S; Chow SY
    Jpn J Antibiot; 1977 Sep; 30(9):650-6. PubMed ID: 916185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.